Catecholamine receptors and signal transduction. Overview.
Goldstein
D S
DS
Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1424, USA.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000322:Adrenergic Agonists / Q000494:pharmacology; D018674:Adrenergic Antagonists / Q000494:pharmacology; D000818:Animals; D001519:Behavior; D001522:Behavior, Animal; D018491:Dopamine Agonists / Q000494:pharmacology; D018492:Dopamine Antagonists / Q000494:pharmacology; D019204:GTP-Binding Proteins / Q000378:metabolism; D006321:Heart / Q000502:physiology; D006801:Humans; D011941:Receptors, Adrenergic / Q000502:physiology*; D017983:Receptors, Catecholamine / Q000819:agonists / Q000037:antagonists & inhibitors / Q000502:physiology*; D015398:Signal Transduction; D010738:Type C Phospholipases / Q000378:metabolism
D000322:Adrenergic Agonists; D018674:Adrenergic Antagonists; D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D011941:Receptors, Adrenergic; D017983:Receptors, Catecholamine; D010738:Type C Phospholipases; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases